Market Research Logo

Global Immunology Market 2018-2022

Global Immunology Market 2018-2022

About Immunology

The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

Technavio’s analysts forecast the global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
Other prominent vendors
  • Angimmune
  • Bionor Pharma
  • Boston Biomedical
  • Celgene
  • Cellectar Biosciences
  • eFFECTOR Therapeutics
  • Forty Seven
  • Immatics Biatechnologies
  • lmmunovaccine
  • Karyopharm Therapeutics
  • MabVax Therapeutics
  • MedImmune
  • Neon Therapeutics
  • NewLink Genetics
  • Novartis
  • Oncotherapeutics.
Market driver
  • Growing cases of infectious diseases
  • For a full, detailed list, view our report
Market trend
  • Significant pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

Press Release

Technavio Announces the Publication of its Research Report – Global Immunology Market 2018-2022

Technavio recognizes the following companies as the key players in the global immunology market: AbbVie, Amgen, F. Hoffmann-La Roche, and Johnson & Johnson.

Other Prominent Vendors in the market are: Angimmune, Bionor Pharma, Boston Biomedical, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics, Forty Seven, HANSOH, Immatics Biatechnologies, lmmunovaccine, Karyopharm Therapeutics, MabVax Therapeutics, MedImmune, MOLOGEN, Neon Therapeutics, NewLink Genetics, Novartis, ONCOQUEST, and Oncotherapeutics.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is significant pipeline. There are multiple promising immunological agents in the pipeline, which boost the market growth after their approval. The approval of new therapeutic agents broadens the options available for the treatment and thus leads to the increase in demand for the therapeutic regimen. There are approximately 51 molecules under different clinical trial stages globally. Out of them, 22 molecules are in Phase II, four molecules are in Phase III, 16 molecules are in Phase I, and remaining are in Phase I/Il clinical trials. One of the most promising molecules under development from AbbVie is risankizumab (ABBY-066). Boehringer Ingelheim and AbbVie are jointly working on the molecule to get approval for new indications such as psoriasis, psoriatic arthritis, and Crohn's disease. This combination is currently going through Phase III clinical trial for psoriasis and Phase II for psoriatic arthritis and Crohn's disease.”

According to the report, one of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body’s immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the coming years.

Companies Mentioned

AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Angimmune, Bionor Pharma, Boston Biomedical, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics, Forty Seven, HANSOH, Immatics Biatechnologies, lmmunovaccine, Karyopharm Therapeutics, MabVax Therapeutics, MedImmune, MOLOGEN, Neon Therapeutics, NewLink Genetics, Novartis, ONCOQUEST, and Oncotherapeutics.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global immunology market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global immunology market 2017-2022 ($ billions)
      • Table Global immunology market: Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase
    • Table Key clinical trials
  • Market segmentation by category
    • Segmentation by category
      • Table Global immunology market by category 2017-2022 (%)
    • Comparison by category
      • Table Comparison by category
    • Global immunosuppressants market
      • Table Immunosuppressant drugs
      • Table Global immunosuppressants market 2017-2022 ($ billions)
      • Table Global immunosuppressants market: Year-over-year growth 2018-2022 (%)
    • Global immuno boosters market
      • Table Classification of immuno boosters
      • Table Global immuno boosters market 2017-2022 ($ billions)
      • Table Global immuno boosters market: Year-over-year growth 2018-2022 (%)
    • Market opportunity by category
      • Table Market opportunity by category
  • Market segmentation by indication
    • Autoimmune diseases
    • Oncology
      • Table Brief history of immuno-oncology
      • Table Stages of anti-tumor immune response
    • Organ transplantation
    • Others
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global immunology market by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Immunology market in Americas
      • Table Immunology market in Americas 2017-2022 ($ billions)
      • Table Immunology market in Americas: Year-over-year growth 2018-2022 (%)
      • Table Top three countries in Americas
    • Immunology market in EMEA
      • Table Immunology market in EMEA 2017-2022 ($ billions)
      • Table Immunology market in EMEA: Year-over-year growth 2018-2022 (%)
      • Table Top three countries in EMEA
    • Immunology market in APAC
      • Table Immunology market in APAC 2017-2022 ($ billions)
      • Table Immunology market in APAC: Year-over-year growth 2018-2022 (%)
      • Table Top three countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Rise in organ transplantation in US 2015-2016
      • Table Organ transplantation by donor type 2016
    • Market challenges
  • Market trends
    • Significant pipeline
    • Collaborations and partnerships for R&D
    • Advanced diagnostic technologies
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie: Vendor overview
      • Table AbbVie: Business segments
      • Table AbbVie: Organizational developments
      • Table AbbVie: Geographic focus
      • Table AbbVie: Segment focus
      • Table AbbVie: Key offerings
    • Amgen
      • Table Amgen: Vendor overview
      • Table Amgen: Business segments
      • Table Amgen: Organizational developments
      • Table Amgen: Geographic focus
      • Table Amgen: Segment focus
      • Table Amgen: Key offerings
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Vendor overview
      • Table F. Hoffmann-La Roche: Business segments
      • Table F. Hoffman-La Roche: Organizational developments
      • Table F. Hoffmann-La Roche: Geographic focus
      • Table F. Hoffmann-La Roche: Segment focus
      • Table F. Hoffmann-La Roche: Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson: Vendor overview
      • Table Johnson & Johnson: Business segments
      • Table Johnson & Johnson: Organizational developments
      • Table Johnson & Johnson: Geographic focus
      • Table Johnson & Johnson: Segment focus
      • Table Johnson & Johnson: Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report